The new cardiobiology: engineering, vascular, and molecular insights

Cardiovascular disease is the leading cause of human mortality, and despite an active research community many of the underlying mechanisms are unknown. Open questions surround molecular triggers, the relationship of GxE, impact of epigenetics, the role of sex, inflammation and microbiome, as well as metabolism and multi-organ links in cardiovascular disease. Advanced molecular and human-mimicking tissue engineering techniques are revolutionizing the way we approach cardiovascular discovery research. These developments led to the inaugural “The new cardiobiology” meeting at EMBL in 2024.

In light of further technical advances in the field, the conference will repeat in 2026 and seek to unite speakers across cardiac and vascular biology, tissue engineering as well as systems biology to continue studying cardiovascular disease.